Mercy Health Research

Washington, Missouri 63090

0 studies enrolling now · 6 studies all time

What they study most

Cellulite, Central Abdominal Bulging, Diabetes Mellitus, Type 2, Edematous Fibrosclerotic Panniculopathy, Edematous Fibrosclerotic Panniculopathy (EFP), Heart Failure, Hyperlipidemia

Studies at this site

• A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure — Completed
• A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes — Completed
• Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2) — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) — Completed
• A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy — Completed